NEW YORK (GenomeWeb) – NeoGenomics today announced it has entered into a research agreement with Northwestern University's Robert H. Lurie Comprehensive Cancer Center and the Northwestern Medicine Developmental Therapeutics Institute. The partners will start a large translational program to establish the clinical utility of comprehensive genomic profiling technologies throughout the development of cancer therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.